首页> 外国专利> Method for quickly normalize Vitamin B12 levels in patients with Vitamin B12 deficiency and an average level of vitamin B12 below 350 pg / ml

Method for quickly normalize Vitamin B12 levels in patients with Vitamin B12 deficiency and an average level of vitamin B12 below 350 pg / ml

机译:快速正常化维生素B12缺乏症且维生素B12平均水平低于350 pg / ml的患者的方法

摘要

This paper introduces the methods of standardization of vitamin B12 in patients with low vitamin B12 content and the methods of standardization of internal variability in the treatment of these patients. Methods to reduce the levels of MMA (methylmalonic acid) and / or isomers and effective drug synthesis to achieve these changes are also described. Requirement 1: a method for rapidly standardizing vitamin B12 levels in patients with vitamin B12 deficiency and vitamin B12 levels below 350 pg / ml, including administration for at least 15 days per day,One or more oral contraceptives containing an N - [8 - (2-hydroxybenzoic acid) amino group or a medically acceptable acrylic acid (II) vitamin B12, and an optional trefoil, In this substance, the daily total amount of propylene - [8 - (2-hydroxybenzoic acid) or medically acceptable acrylate is 50-250 mg, and the daily total dose of vitamin B12 is 0.5-2 mg,Normalize vitamin B12 levels within 15 days. ILO Convention No. 7: a method of reducing the content of methylmalonic acid in a patient with a high content of MMA, in which the content of MMA is at least 150 ml / L, Methods containing one or more oral doses, including (I) n [8 - (2-hydroxybenzoic acid) amino or containing a pharmaceutically acceptable propene (II) vitamin B12, or optional (III) folic acid,The daily total amount of oxyacetic acid (n - [8 - (2-hydroxybenzoic acid) or acceptable medicament salt is 50-250 mg, the daily total dose of vitamin B12 is 0.5-2 mg, and the patient's MMA level is standardized within 15 days. ILO Convention No. 11: a way to reduce the level of homosexuality of high standard homosexual patients, in which the level of homosexuality of patients is at least 13 ml / L, Methods containing one or more oral doses, including (I) octa (n - [2-hydroxybenzoic acid) amino group or a pharmaceutically acceptable salt,(II) vitamin B12, as well as selective (III) folic acid, in which n - [8 - (2-hydroxybenzoic acid) amino] or salts with drug acceptability have a total daily dose of 50-250 mg and a total daily dose of vitamin B12 of 0.5-2 mg, There, patients' homosexuality levels normalized within 15 days. ILO Convention No. 16: an oral dosage form consisting of: (a) vitamin B12 (b) n - [8 - (2-hydroxybenzoic acid) amino or a medically acceptable acrylic acid, and (c) folic acid. ILO Convention No. 17: Convention No. 16.Dosage forms include 50-250 mg of N - [8 - (2-hydroxybenzoic acid) amino or a pharmaceutically acceptable salt, and 0.5-2 mg of vitamin B12. ILO Convention No. 18: an oral dosage form consisting of: (a) proton pump inhibitors; (b) vitamin B1; (c) n - [8 - (2-hydroxybenzoic acid) sodium amino acid; and (d) folic acid. ILO Convention No. 20: an oral contraceptive consisting of: (a) formaldehyde; (b) vitamin B12 (c) n - [8 - (2-hydroxybenzoic acid) sodium amino acid and (d) acetic acid.
机译:本文介绍了维生素B12含量低的患者中维生素B12的标准化方法以及这些患者治疗中内部变异性的标准化方法。还描述了降低MMA(甲基丙二酸)和/或异构体水平的方法,以及实现这些变化的有效药物合成方法。要求1:一种快速标准化维生素B12缺乏症和维生素B12水平低于350 pg / ml的患者中维生素B12水平的方法,包括每天给药至少15天,一种或多种含有N-[8-( (2-羟基苯甲酸)氨基或医学上可接受的丙烯酸(II)维生素B12,以及可选的三叶,在这种物质中,丙烯-[8-(2-羟基苯甲酸)或医学上可接受的丙烯酸酯的日总量为50 -250毫克,维生素B12的每日总剂量为0.5-2毫克,请在15天内正常化维生素B12的水平。国际劳工组织第7号公约:降低MMA含量高的患者中甲基丙二酸含量的方法,其中MMA含量至少为150 ml / L,包含一个或多个口服剂量的方法,包括(I )n [8-(2-羟基苯甲酸)氨基或含有药学上可接受的丙烯(II)维生素B12或可选的(III)叶酸,每天的乙酸氧总量(n-[8-(2-羟基苯甲酸)或可接受的药物盐为50-250毫克,维生素B12的每日总剂量为0.5-2毫克,患者的MMA水平在15天之内达到标准。国际劳工组织第11号公约:降低同性恋者同性恋水平的方法高标准同性恋患者,其中患者的同性恋水平至少为13 ml / L,包含一个或多个口服剂量的方法,包括(I)八(n- [2-羟基苯甲酸)氨基或药学上可接受的盐,(II)维生素B12以及选择性(III)叶酸,其中n-[8-(2-羟基苯甲酸[氨基酸]或具有药物可接受性的盐的每日总剂量为50-250 mg,维生素B12的总每日剂量为0.5-2 mg。在那里,患者的同性恋水平在15天内恢复正常。国际劳工组织第16号公约:口服剂型,包括:(a)维生素B12(b)n-[8-(2-羟基苯甲酸)氨基或医学上可接受的丙烯酸,和(c)叶酸。国际劳工组织第17号公约:第16号公约。剂型包括50-250毫克N-[8-(2-羟基苯甲酸)氨基或可药用盐,以及0.5-2毫克维生素B12。国际劳工组织第18号公约:口服剂型,其组成为:(a)质子泵抑制剂; (b)维生素B1; (c)n-[8-(2-羟基苯甲酸)氨基酸钠; (d)叶酸。国际劳工组织第20号公约:一种口服避孕药,其组成如下:(a)甲醛; (b)维生素B12(c)n-[8-(2-羟基苯甲酸)氨基酸钠和(d)乙酸。

著录项

  • 公开/公告号AR080292A1

    专利类型

  • 公开/公告日2012-03-28

    原文格式PDF

  • 申请/专利权人 EMISPHERE TECHNOLOGIES INC.;

    申请/专利号AR2011P100553

  • 发明设计人

    申请日2011-02-23

  • 分类号A61K31/519;A61K31/197;A61K31/714;A61K9/20;A61P3/02;A61P1/04;A61P3/10;

  • 国家 AR

  • 入库时间 2022-08-21 17:25:35

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号